A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical trial NCT07749586 · RECRUITING

Trial details

NCT number: NCT07749586
Sponsor: Arvinas Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2026-07-29
Primary completion: 2031-03-31
Enrollment: 499

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.